From lab to label: Aligning trademark strategy with regulatory approval
Speakers
Pharmaceutical trademarks face a uniquely complex approval landscape—requiring alignment between the legal standards of the USPTO and the safety-driven scrutiny of the FDA.
In this insightful session, we explore the unique challenges and regulatory nuances of pharmaceutical trademark development. Whether you’re in branding, legal, or regulatory affairs, this webinar will equip you with practical knowledge to navigate the complex landscape of drug name approval.
Key insights and takeaways:
• Understanding the uniqueness of pharmaceutical trademarks
• Common pitfalls and challenges in name development
• A brief history of FDA name review and why it matters
• Key differences between FDA and USPTO review processes
• What leads to name rejections and how to avoid them
• Best practices for trademark clearance in pharma
• Actionable takeaways to strengthen your trademark strategy
Watch the recording below now:
